Open Rank of UNM Cancer Center in Molecular Medicine - Breast Physician Translational Scientist - req# 3271
Open Rank of UNM Cancer Center in Molecular Medicine - Breast Physician Translational Scientist
|Faculty Type||Open Rank|
|Hiring Department||Division of Molecular Medicine (099X)|
|Academic Location||School of Medicine|
|Benefits Eligible||The University of New Mexico provides a comprehensive package of benefits including medical, dental, vision, and life insurance. In addition, UNM offers educational benefits through the tuition remission and dependent education programs. See the Benefits home page for more information.|
The University of New Mexico National Cancer Institute (NCI) Designated Comprehensive Cancer Center (UNMCCC), and the Department of Medicine, Divisions of Molecular Medicine and Hematology/Oncology, and the Department of Pathology at the UNM School of Medicine, invite applications from scientists and physicians with expertise in fundamental to translational and translational to clinical research focused on breast cancer. The successful applicant will also provide leadership and scientific expertise UNMCCC Research Program and Multidisciplinary Scientific Group in Breast Cancer. The multiethnic populations of New Mexico (primarily Hispanic, American Indian, and Non-Hispanic White) are particularly affected by striking disparities in the incidence and mortality of breast cancer, affording many unique research opportunities. The UNMCCC and UNM School of Medicine have an outstanding and highly collaborative cadre of investigators from multiple specialties (Oncology, Surgery, Pathology, and Laboratory and Population Sciences) focused on developing innovative methods for early detection and screening of these cancers, for cancer behavioral and cancer control interventions to overcome disparities, in discovery-focused laboratory investigations, in translational research using primary human tissue samples and animal model systems, and in clinical research focused on the development of investigator-initiated and early phase clinical trials. Applications are invited from scientists and physicians (M.D., M.D/Ph.D., or Ph.D.) trained in any oncology relevant specialty with expertise in research relevant to the study of these cancers. While these positions are Open Rank, successful applicants will have a sustained track record of research-focused academic accomplishments with peer-reviewed extramural funding (NIH, NCI, or equivalent); expertise in fundamental, translational, or clinical cancer research; and, the ability to develop and lead highly collaborative multidisciplinary research teams. Significant resources, including Endowed Chairs and Professorships, excellent salaries, outstanding laboratory space and research resources, clinical research infrastructure, and comprehensive start-up packages are available. Opportunities also exist for academic leadership roles and Senior Leadership positions within the UNMCCC.
The University of New Mexico Comprehensive Cancer Center (UNMCCC) is the Official Cancer Center of New Mexico and the only National Cancer Institute (NCI) Designated Comprehensive Cancer Center in a 500-mile radius. The 134 oncology physicians, 122 cancer research scientists, and staff are particularly focused on discovering the causes and the cures for cancers that disproportionately affect the people of the American Southwest - primarily Hispanic, American Indian, and Non-Hispanic White - with strikingly different patterns of cancer incidence, mortality and disparity. The Center treated 12,000 unique patients in FY17, 15% of whom participated in therapeutic interventional studies and 35% of whom participated in interventional studies. The UNMCCC has outstanding research programs in Cancer Control and Cancer Health Disparities; Cancer Genetics, Epigenetics, and Genomics; Cancer Cell and Systems Biology; and Cancer Therapeutics. These programs house several national centers including: The Molecular Discovery and High Throughput Target Screening Center (nmmlsc.health.unm.edu), one of the nation’s 6 Chemical Biology Consortium Centers of Excellence in The NCI NExT Program; The New Mexico Center for the Spatiotemporal Modeling of Cell Signaling (stmc.health.unm.edu), one of 13 NIH National Centers for Systems Biology; and a NIH Clinical and Translational Sciences Center. Rich collaborations with UNMCCC partners (Sandia and Los Alamos National Laboratories; Lovelace Respiratory Research Institute) with unparalleled computing and technology infrastructure enrich our research endeavors. The UNMCCC is the center of a collaborative statewide cancer clinical trials and health delivery research network and is funded by a NCI NCORP Grant (Minority/Underserved), and is also a member of the ORIEN National Cancer Precision Medicine Network (http://oriencancer.org/). Center members have conducted more than 60 statewide community-based cancer education, prevention, screening, and behavioral intervention studies involving more than 10,000 New Mexicans. Learn more at http://cancer.unm.edu/
Complete applications will include a cover letter, curriculum vitae, and the names of three references with mailing address, phone numbers and email address.
For all inquiries or questions, please contact: Search Chair: Dr. Eric Prossnitz, PhD at (EProssnitz@salud.unm.edu) or Dr. Dennis McCance at (DMcCance@salud.unm.edu), or, Search Coordinator: Amanda Leigh at: (email@example.com) or (505) 272-2201.
|For Best Consideration||For best consideration, please apply by . This position will remain open until filled.|
The University of New Mexico is committed to hiring and retaining a diverse workforce. We are an Equal Opportunity Employer, making decisions without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, veteran status, disability, or any other protected class.